RECRUITINGOBSERVATIONAL

Regenerative Injection of Stem Cells or Stem Cell-derived Exosomes for Erectile Dysfunction (RISE)

Prospective Observational Study on Intracavernosal Injection of Autologous Adipose Tissue-Derived Stem Cells (ADSC) or Stem Cell-derived Exosomes for the Treatment of Erectile Dysfunction

About This Trial

The goal of this prospective observational study is to evaluate whether injections of stem cells derived from the patient's own fat tissue (adipose tissue) can improve erectile function in men aged 30 to 75 who have erectile dysfunction (ED) and have not responded well to standard treatments like PDE-5 inhibitors (e.g., Viagra). The main questions the study aims to answer are: Will the stem cell injections improve erectile function, as measured by the International Index of Erectile Function (IIEF) score? Are there any changes in blood flow to the penis, which will be measured using a Doppler ultrasound? Participants will: Receive injections of their own stem cells (obtained from a biopsy of fat) directly into the penis. Undergo assessments to check erectile function before and after treatment. Have follow-up visits at 3, 6, 9, and 12 months to monitor long-term effects. The study will also look for any possible side effects or complications and evaluate biological markers in the penis that may indicate the effectiveness of the treatment. Participants will be recruited from clinic where they are already receiving care for ED. To take part, they must be in good overall health, with no severe heart disease, uncontrolled diabetes, cancer, or other conditions that could make stem cell therapy unsafe for them.

Who May Be Eligible (Plain English)

Who May Qualify: - Age: Adult males aged 30 to 75 years. - Diagnosis: Confirmed diagnosis of erectile dysfunction (ED) of mild to moderate severity, as defined by an International Index of Erectile Function (IIEF) score. - Treatment Response: Failure or suboptimal response to conventional ED treatments, such as PDE-5 inhibitors. - General Health: Overall good health without contraindications to stem cell therapy. - willing to sign a consent form: Ability and willingness to provide written willing to sign a consent form to participate in the study. Who Should NOT Join This Trial: - Severe Cardiovascular Disease: Presence of severe cardiovascular conditions, including uncontrolled hypertension or significant heart disease. - Active Infections: Ongoing infections that could interfere with treatment or pose a risk to the participant. - Malignancies: History of or current cancer, including malignancies that could affect safety or treatment outcomes. - Contraindications to Stem Cell Therapy: Any medical conditions or treatments that contraindicate the use of stem cell therapy. - Uncontrolled Diabetes: Poorly controlled diabetes or other metabolic disorders that could impact treatment efficacy or safety. - Psychiatric or Cognitive Impairments: Significant psychiatric or cognitive disorders that may affect the participant\'s ability to comply with study protocols or provide willing to sign a consent form. - Recent Surgery or Trauma: Recent major surgeries or physical trauma that could impact the study or interfere with the intervention. - Participation in Other Studies: Participation in other clinical trials or studies that may affect the outcomes or safety of this study. Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language

Inclusion Criteria: * Age: Adult males aged 30 to 75 years. * Diagnosis: Confirmed diagnosis of erectile dysfunction (ED) of mild to moderate severity, as defined by an International Index of Erectile Function (IIEF) score. * Treatment Response: Failure or suboptimal response to conventional ED treatments, such as PDE-5 inhibitors. * General Health: Overall good health without contraindications to stem cell therapy. * Informed Consent: Ability and willingness to provide written informed consent to participate in the study. Exclusion Criteria: * Severe Cardiovascular Disease: Presence of severe cardiovascular conditions, including uncontrolled hypertension or significant heart disease. * Active Infections: Ongoing infections that could interfere with treatment or pose a risk to the participant. * Malignancies: History of or current cancer, including malignancies that could affect safety or treatment outcomes. * Contraindications to Stem Cell Therapy: Any medical conditions or treatments that contraindicate the use of stem cell therapy. * Uncontrolled Diabetes: Poorly controlled diabetes or other metabolic disorders that could impact treatment efficacy or safety. * Psychiatric or Cognitive Impairments: Significant psychiatric or cognitive disorders that may affect the participant\'s ability to comply with study protocols or provide informed consent. * Recent Surgery or Trauma: Recent major surgeries or physical trauma that could impact the study or interfere with the intervention. * Participation in Other Studies: Participation in other clinical trials or studies that may affect the outcomes or safety of this study.

Treatments Being Tested

PROCEDURE

Autologous Adipose Tissue-Derived Stem Cell Injection for Erectile Dysfunction

This intervention involves the use of autologous adipose tissue-derived stem cells (ADSC) to treat erectile dysfunction. The process begins with a minimally invasive liposuction procedure to harvest fat tissue from the participant\'s own body. The harvested fat is then processed to isolate stem cells, which are subsequently injected directly into the erectile tissue of the penis. This approach aims to enhance erectile function by promoting tissue regeneration and improving blood flow. Unlike other treatments for erectile dysfunction, this intervention uses stem cells derived from the participant\'s own fat, which may reduce the risk of immune rejection and offer a novel regenerative therapy option. The treatment is designed to address ED in patients who have not responded adequately to conventional therapies like PDE-5 inhibitors.

PROCEDURE

Stem cell-derived Exosomes Injection for Erectile Dysfunction

This intervention involves the use of stem cell-derived exosomes to treat erectile dysfunction. Exosomes are nano-sized extracellular vesicles secreted by stem cells, containing bioactive molecules such as growth factors and signaling proteins that promote tissue repair and regeneration. Unlike therapies requiring the transplantation of live cells, this cell-free approach eliminates the need for invasive harvesting procedures. The exosomes are carefully purified from cultured stem cells and prepared for direct injection into the erectile tissue of the penis. This approach aims to enhance erectile function by stimulating tissue regeneration, reducing inflammation, and improving blood flow. Unlike other treatments for erectile dysfunction, exosome therapy offers a novel regenerative option, potentially benefiting patients who have not responded adequately to conventional therapies such as PDE-5 inhibitors.

Locations (1)

Jumeirah American Clinic

Dubai, Dubai, United Arab Emirates